Projects per year
Phil Bardin is Professor of Respiratory Medicine in the Faculty of Medicine, Nursing & Health Sciences, Monash University, Melbourne, Australia. Currently he is also Director, Lung & Sleep Medicine, Monash University and Medical Centre, Melbourne.
He is recognised for investigation of obstructive lung diseases (particularly virusasthma-COPD exacerbations) and has conducted extensive research of new asthma and COPD therapies. Recently research has examined vocal cord dysfunction in obstructive lung diseases. Professional activities reflect a career-long commitment to research and medical education, particularly in the areas of asthma and COPD.
He is a recipient of ongoing Australian NH&MRC funding, has chaired the Australian NH&MRC Grant Review Panel (Respiratory & Sleep Medicine) and served on the Australian NH&MRC Academy. Currently he is Co-Editor of Respirology, official journal of the TSANZ and APSR.
Medicine, FRACP, Royal Australasian College of Physicians (RACP)
Award Date: 1 Jan 2003
PhD, University of Southampton
Award Date: 1 Jan 1994
Medicine, FCPSA, Colleges of Medicine of South Africa
Award Date: 1 Jan 1985
Co-Editor in Chief, Respirology
1 Jan 2017 → …
Director Monash Lung and Sleep, Monash Health
1 Mar 2012 → …
Research area keywords
- Laryngeal dysfunction
- bacterial respiratory disease
- virus pathogenesis
Dive into details
Select a country/territory to view shared publications and projects
A 12-week, randomized, participant-and investigator-blinded, placebo-controlled, parallel group study to explore the efficacy, pharmacodynamics, safety, and pharmacokinetics of two doses of inhaled CSJ117 in adults with Chronic Obstructive Pulmonary Disease (COPD)
14/04/22 → 13/04/27
1/01/22 → 31/12/24
NIMBLE Study - A 52-week, randomised, double-blind, double-dummy, parallel group, multi-centre, non-inferiority study assessing exacerbation rate, additional measures of asthma control and safety in adult and adolescent severe asthmatic participants with an eosinophilic phenotype treated with GSK3511294 compared with mepolizumab or benralizumab
20/12/21 → 19/12/26
1/01/20 → 31/12/22
Fukusho, R., Ruane, L., Phyland, D., Koh, J., Avram, A., Leong, P., MacDonald, M., Lau, K. K., Baxter, M. & Bardin, P. G., Feb 2022, In: Journal of Allergy and Clinical Immunology: In Practice. 10, 2, p. 612-614.e1 4 p.
Research output: Contribution to journal › Article › Other › peer-review
Leong, P., Phyland, D. J., Koh, J., Baxter, M. & Bardin, P. G., Jan 2022, In: The Lancet Respiratory Medicine. 10, 1, p. 3-5 3 p.
Research output: Contribution to journal › Comment / Debate › Other › peer-review
Leong, P., Osadnik, C. R., King, P. T., MacDonald, M. I., Ko, B. S., Lau, K. K., Joosten, S. A., Kathriachchige, G., Chua, A., Hamza, K., Kuganesan, A., Troupis, J. M. & Bardin, P. G., Jan 2022, In: Respirology. 27, 1, p. 56-65 10 p.
Research output: Contribution to journal › Article › Research › peer-reviewOpen Access
Gillman, A., Harrington, J., Hew, M., Bardin, P., Peters, M., Reynolds, P. N., Langton, D., Baraket, M., Bowden, J. J., Bowler, S., Chien, J., Chung, L. P., Farah, C. S. & 10 others, , Jul 2021, In: Journal of Allergy and Clinical Immunology: In Practice. 9, 7, p. 2715-2724.e5 15 p.
Research output: Contribution to journal › Article › Research › peer-review
Oral corticosteroids stewardship for asthma in adults and adolescents: A position paper from the Thoracic Society of Australia and New ZealandBlakey, J., Chung, L. P., McDonald, V. M., Ruane, L., Gornall, J., Barton, C., Bosnic-Anticevich, S., Harrington, J., Hew, M., Holland, A. E., Hopkins, T., Jayaram, L., Reddel, H., Upham, J. W., Gibson, P. G. & Bardin, P., Dec 2021, In: Respirology. 26, 12, p. 1112-1130 19 p.
Research output: Contribution to journal › Review Article › Research › peer-reviewOpen Access